Excerpta Medica and Elsevier Interactive Solutions Merge Into One Integrated Provider
Health care organizations seeking effective marketing and education solutions now have a single source -- Excerpta Medica -- for compelling, integrated online and offline communication
Bridgewater, NJ, October 12, 2007 - Excerpta Medica, an Elsevier business that has delivered medical communications for over six decades, has merged with corporate sibling Elsevier Interactive Solutions (EIS), an award-winning interactive health communications agency with more than a decade's experience creating online marketing and educational programs for leading healthcare brands. Excerpta Medica will now be able to offer customers in the pharmaceutical and biotechnology industries a full range of comprehensive, turn-key communication solutions that combine important and timely clinical content with innovative online tools.
"As the online channel becomes increasingly important to our clients, we can now provide them with seamless access to a proven pioneer in interactive health care marketing," says Greg Samios, President of Excerpta Medica. "Health care organizations now have a choice: juggle work amongst several agencies for integrated campaigns, or work with us and benefit from the time- and cost-savings of having all the services they need in one organization."
To reflect the merger, EIS has changed its name to Excerpta Medica Interactive and will operate as a division of Excerpta Medica. Excerpta Medica Interactive will service clients globally from its offices in Toronto.
# # #
About Excerpta Medica
Excerpta Medica, an Elsevier business, is a global communications company that services health care clients in the areas of medical education, medical communications, publication planning, and interactive solutions. Excerpta Medica brings an experienced team of professionals from pharmaceuticals, health care, medical publishing and online marketing to deliver scientific and creative solutions. Excerpta Medica has offices in the US, The Netherlands, and Canada.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+1 908 547 2130